Elevation Wealth Partners’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
Other funds holding RMD
Elevation Wealth Partners's RMD Position: Q3 2026 in Review
Elevation Wealth Partners increased its ResMed (RMD) stake by 638% in Q3 2026, buying an estimated $22.3K and bringing the position to 118 shares worth $26.1K. The position accounts for 0.01% of the portfolio, ranked #595.
Elevation Wealth Partners first reported a position in RMD in Q3 2025 and has held it in 4 quarters since. 231 funds tracked by Wall St. Rank hold RMD as of Q3 2026.
- Elevation Wealth Partners held 118 shares of ResMed worth $26.1K as of Q3 2026.
- Elevation Wealth Partners bought 102 ResMed shares in Q3 2026, an estimated $22.3K.
- ResMed made up 0.01% of Elevation Wealth Partners's portfolio in Q3 2026, its #595 holding.
- Elevation Wealth Partners first reported a position in ResMed in Q3 2025 and has held it in 4 quarters since.
- 231 funds tracked by Wall St. Rank held ResMed as of Q3 2026.
Based on Elevation Wealth Partners's 13F filing for Q3 2026, filed 7 Oct 2026.